Elevance Health Inc/ US0367521038 /
| 24.12.2024 23:00:00 | Diff. +2,0500 | Volumen | Geld24.12.2024 | Brief24.12.2024 | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 372,9400USD | +0,55% | 468.226 Umsatz: 110,42 Mio. |
369,0000Geld Vol: 700 | 380,7800Brief Vol: 100 | 86,49 Mrd.USD | 1,59% | 14,69 |
Aktiva
| 2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 1.738,3000 | 1.801,5000 | 1.944,3000 | 2.019,8000 | 1.977,9000 | ||||||
| Immaterielle Vermögensgegenstände | 9.102,8000 | 8.441 | 7.958,1000 | 8.158 | 7.964,9000 | ||||||
| Finanzanlagen | - | - | 2.231,8000 | 2.630,3000 | 2.796,3000 | ||||||
| Anlagevermögen | - | - | 29.836,1000 | 30.855,7000 | 30.768,2000 | ||||||
| Vorräte | - | - | - | - | - | ||||||
| Forderungen | - | - | - | 11.943,6000 | 14.426,9000 | ||||||
| Liquide Mitteln | 2.484,6000 | 1.582,1000 | 2.151,7000 | 2.113,5000 | 4.075,3000 | ||||||
| Umlaufvermögen | 28.268,4000 | 29.745,8000 | 32.228,9000 | 30.862,1000 | 34.314,9000 | ||||||
| Aktiva, gesamt | 58.955,4000 | 59.574,5000 | 62.065 | 61.717,8000 | 65.083,1000 | ||||||
Passiva
| 2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 3.132,5000 | 3.426,3000 | - | 10.888,6000 | 11.907,5000 | ||||||
| Langfristige Schulden | - | - | 14.127,2000 | 15.324,5000 | 14.358,5000 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | 250 | 400 | 400 | 540 | 440 | ||||||
| Rückstellungen | 4.131,8000 | 4.048,2000 | 3.897,3000 | 3.262,3000 | 3.446 | ||||||
| Verbindlichkeiten | 35.152,7000 | 34.809,3000 | 37.813,7000 | 38.673,7000 | 39.982,7000 | ||||||
| Gezeichnetes Kapital | 3 | 2,9000 | - | 2,6000 | 2,6000 | ||||||
| Eigenkapital | 23.802,7000 | 24.765,2000 | 24.251,3000 | 23.044,1000 | 25.100,4000 | ||||||
| Minderheitenanteile | 0.0000 | 0.0000 | - | - | - | ||||||
| Passiva, gesamt | 58.955,4000 | 59.574,5000 | 62.065 | 61.717,8000 | 65.083,1000 | ||||||
Gewinn- und Verlustrechnung
| 2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 61.711,7000 | 71.023,5000 | 73.874,1000 | 79.156,5000 | 84.863 | ||||||
| Abschreibungen (Gesamt) | 245,1000 | 245,3000 | 220,9000 | 230,1000 | 192,3000 | ||||||
| Betriebsergebnis | 4.377,3000 | 4.442,9000 | 4.418,4000 | 4.753,1000 | 4.801,7000 | ||||||
| Zinsergebnis | -511,8000 | -602,7000 | 600,7000 | -653 | -723 | ||||||
| Ergebnis vor Steuern | 3.865,5000 | 3.840,2000 | 4.368,1000 | 4.631 | 4.555,4000 | ||||||
| Ertragsteuern | 1.210 | 1.205,9000 | 1.808 | 2.071 | 2.085,6000 | ||||||
| Gewinnanteil Minderheitsgesellschafter | 0.0000 | 0.0000 | - | - | - | ||||||
| Konzernjahresüberschuss | 2.655,5000 | 2.489,7000 | 2.569,7000 | 2.560 | 2.469,8000 | ||||||
Pro Aktie
Cash Flow
| 2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 2.744,6000 | 3.052,3000 | 3.369,3000 | 4.116 | 3.204,5000 | ||||||
| Cash Flow aus Investitionstätigkeit | -4.551,6000 | -2.234,4000 | -974,9000 | -1.151,5000 | -513,9000 | ||||||
| Cash Flow aus Finanzierungstätigkeit | 2.088,9000 | -1.717,8000 | -1.822,5000 | -2.997,4000 | -732,9000 | ||||||
| Veränderung der liquiden Mittel | 283 | -897,7000 | 564,8000 | -38,2000 | 1.961,8000 | ||||||
| Anzahl der Mitarbeiter | 43.500 | 48.200 | 51.500 | 53.000 | 53.000 | ||||||
